TPE Filtration Sets
TPE 1000 and TPE 2000 Pre-connected Sets for Therapeutic Plasma Exchange, powered by the PrisMax and Prismaflex systems.
Therapeutic plasma exchange is associated with positive clinical outcomes1
Therapeutic plasma exchange (TPE) is an extracorporeal blood purification technique used to treat patients with a variety of disorders; it has become a relatively common treatment modality. It is associated with positive clinical outcomes in the treatment of Guillain-Barré syndrome, thrombotic thrombocytopenic purpura (TTP), myasthenia gravis and Goodpasture syndrome.
Filtration TPE sets powered by PrisMax and Prismaflex expand treatment options in the ICU
Simplicity and improved ease of use for TPE delivery
Setting up and delivering TPE therapy on the PrisMax and Prismaflex systems is similar to setting up a CRRT procedure.2
The intuitive user interface of the PrisMax and Prismaflex systems may help to support therapy initiation.2,3
The systems offer the capability for citrate anticoagulation and an integrated syringe pump for heparin anticoagulation.2
Enhanced safety features for greater confidence
The PrisMax and Prismaflex systems offer the ability to delay the start of therapy until the TPE circuit has been filled with blood before initiating treatment.2
The self-regulating pressure system can automatically accommodate blood flow rate adjustments.2
Flow-rate capabilities allow adjustments for lower-body-weight patients.2
TPE 2000 set | TPE 1000 set | |
Patient Weight | Adult | >9 kg |
Effective Surface Area | 0.35 m2 | 0.15 m2 |
Blood Priming Volume | 41 mL ± 10% | 23 mL ± 10% |
Blood Volume in Set
| 125 mL ± 10% | 71 mL ± 10% |
Minimum Blood Flow Rate | 100 mL/min | 50 mL/min |
Maximum Blood Flow Rate | 400 mL/min | 180 mL/min |
Plasmafilter Hollow Fiber | Polypropylene | Polypropylene |
Vantive, Prismaflex and PrisMax are trademarks of Vantive Health LLC or its affiliates.
References
-
Padmanabhan A, Connelly‐Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019;34:171-354.
-
Vantive Health LLC. PrisMax Operator’s Manual AW8061. 2024.
-
Broman M, Bell M, Joannes-Boyau O, Ronco C. The novel PrisMax Continuous Renal Replacement Therapy system in a multinational,multicentre pilot setting. Blood Purif. 2018;46:220-227.